OBJECTIVES: Recognizing the uniqueness of secondary dengue virus (DENV)-1/3 dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) cases at an interval of 24 years, we sought to estimate DENV infections as well as the ratios between mild disease and DHF/DSS by DENV infection sequence in Playa District (Havana, Cuba) during the 2001-2002 outbreak of dengue virus type 3 (DENV-3). METHODS: A retrospective seroepidemiological study was conducted in 2003 in Playa District. Blood samples were collected from a 1% random sample of residents and were studied for the prevalence of dengue neutralizing antibodies. RESULTS: DENV-3 was found to have infected 7.2% (95% confidence interval (95% CI) 6.0-8.4%) of susceptible individuals (the entire cohort), the majority of whom experienced silent infections. Virtually every individual who had a secondary infection in the sequence DENV-1 then DENV-3 became ill, with a ratio of severe to mild cases of 1:35 (95% CI 1:67-1:23). Secondary infections in the sequence DENV-2/3 were less pathogenic than DENV-1/3. Mild disease accompanying secondary DENV2/3 occurred at a ratio of 1:4.49 infections (95% CI 1:5.77-1:3.42) secondary infections. CONCLUSIONS: The results obtained highlight the role of the infecting serotype and also the sequence of the viral infection in the clinical outcome of a dengue infection.
OBJECTIVES: Recognizing the uniqueness of secondary dengue virus (DENV)-1/3 dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) cases at an interval of 24 years, we sought to estimate DENV infections as well as the ratios between mild disease and DHF/DSS by DENVinfection sequence in Playa District (Havana, Cuba) during the 2001-2002 outbreak of dengue virus type 3 (DENV-3). METHODS: A retrospective seroepidemiological study was conducted in 2003 in Playa District. Blood samples were collected from a 1% random sample of residents and were studied for the prevalence of dengue neutralizing antibodies. RESULTS:DENV-3 was found to have infected 7.2% (95% confidence interval (95% CI) 6.0-8.4%) of susceptible individuals (the entire cohort), the majority of whom experienced silent infections. Virtually every individual who had a secondary infection in the sequence DENV-1 then DENV-3 became ill, with a ratio of severe to mild cases of 1:35 (95% CI 1:67-1:23). Secondary infections in the sequence DENV-2/3 were less pathogenic than DENV-1/3. Mild disease accompanying secondary DENV2/3 occurred at a ratio of 1:4.49 infections (95% CI 1:5.77-1:3.42) secondary infections. CONCLUSIONS: The results obtained highlight the role of the infecting serotype and also the sequence of the viral infection in the clinical outcome of a dengue infection.
Authors: Beatriz Sierra; Ana B Pérez; Mayling Alvarez; Gissel García; Katrin Vogt; Eglys Aguirre; Kathrin Schmolke; Hans-Dieter Volk; María G Guzmán Journal: Am J Trop Med Hyg Date: 2012-07-16 Impact factor: 2.345
Authors: Luis Augusto Piedra; Liss Claudia Martinez; Armando Ruiz; Juan Ramon Vazquez; Maria Guadalupe Guzman; Jorge Rey; Juan Andres Bisset Journal: Am J Trop Med Hyg Date: 2021-11-08 Impact factor: 2.345
Authors: Sandra Olkowski; Brett M Forshey; Amy C Morrison; Claudio Rocha; Stalin Vilcarromero; Eric S Halsey; Tadeusz J Kochel; Thomas W Scott; Steven T Stoddard Journal: J Infect Dis Date: 2013-06-17 Impact factor: 5.226
Authors: Chee-Fu Yung; Kim-Sung Lee; Tun-Linn Thein; Li-Kiang Tan; Victor C Gan; Joshua G X Wong; David C Lye; Lee-Ching Ng; Yee-Sin Leo Journal: Am J Trop Med Hyg Date: 2015-03-30 Impact factor: 2.345
Authors: Andreas Neumayr; Jose Muñoz; Mirjam Schunk; Emmanuel Bottieau; Jakob Cramer; Guido Calleri; Rogelio López-Vélez; Andrea Angheben; Thomas Zoller; Leo Visser; Núria Serre-Delcor; Blaise Genton; Francesco Castelli; Marjan Van Esbroeck; Alberto Matteelli; Laurence Rochat; Elena Sulleiro; Florian Kurth; Federico Gobbi; Francesca Norman; Ilaria Torta; Jan Clerinx; David Poluda; Miguel Martinez; Antonia Calvo-Cano; Maria Paz Sanchez-Seco; Annelies Wilder-Smith; Christoph Hatz; Leticia Franco Journal: Euro Surveill Date: 2017-01-05
Authors: Christian Julian Villabona-Arenas; Adriano Mondini; Irene Bosch; Diane J Schimdt; Diane Schimitt; Carlos E Calzavara-Silva; Paolo M de A Zanotto; Maurício L Nogueira Journal: PLoS One Date: 2013-05-07 Impact factor: 3.240
Authors: Rosmari Rodriguez-Roche; Hervé Blanc; Antonio V Bordería; Gisell Díaz; Rasmus Henningsson; Daniel Gonzalez; Emidalys Santana; Mayling Alvarez; Osvaldo Castro; Magnus Fontes; Marco Vignuzzi; Maria G Guzman Journal: J Virol Date: 2016-04-14 Impact factor: 5.103